---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-26-151228"
form_type: "8-K"
ticker: "CVSI"
cik: "0001510964"
company_name: "CV Sciences, Inc."
filed_at: "2026-04-10T23:59:59+00:00"
generated_at: "2026-05-15T06:40:19.974733+00:00"
event_type: "debt"
sentiment: "neutral"
materiality_score: 0.5
calibrated_materiality_score: 0.5
confidence: "high"
source: SEC EDGAR
---

# CV Sciences issues $99,614 senior secured convertible note; conversion price cut to $0.03

## Summary
- Issued $99,614.04 senior secured convertible note due July 6, 2027 to an institutional investor.
- April 9, 2026 amendment reduced fixed conversion price on prior notes from $0.06 to $0.03 per share.
- Third Note conversion price fixed at $0.03 (lesser of $0.03 and prior-day closing price of $0.04).
- No interest accrues unless Event of Default; then 18% late fee per annum applies.
- Conversion subject to 4.99% beneficial ownership limitation (can be increased to 9.99%).

## SEC filing metadata
- accession: 0001193125-26-151228
- form_type: 8-K
- ticker: CVSI
- cik: 0001510964
- company_name: CV Sciences, Inc.
- filed_at: 2026-04-10T23:59:59+00:00
- event_type: debt
- sentiment: neutral
- materiality_score: 0.5
- calibrated_materiality_score: 0.5
- confidence: high
- sec_items: 1.01, 2.03, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1510964/000119312526151228/0001193125-26-151228-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1510964/000119312526151228/cvsi-20260406.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-26-151228
- JSON: https://secwatch.observer/filing/0001193125-26-151228.json
- Plain text: https://secwatch.observer/filing/0001193125-26-151228.txt

## Source-grounded claims
- claim_id: 1b6cb5d566b98a8ddb209ef9e7f7f8f4773710c4
  claim: CV Sciences, Inc. amended senior notes with the Investor maturing July 6, 2027.
  evidence_excerpt: The April Amendment also extended the maturity date of the Third Note to July 6, 2027.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526151228/0001193125-26-151228-index.htm
- claim_id: b72c17770cb7caac422663d20501e8d8d8853781
  claim: CV Sciences, Inc. incurred senior notes of $99,614.04 with an institutional investor maturing April 6, 2027.
  evidence_excerpt: On April 6, 2026, the Company issued the Investor a Third Note with a principal amount of $99,614.04.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526151228/0001193125-26-151228-index.htm
- claim_id: 3b2d0df7e161456c61c71dcf636ea871615f897d
  claim: CV Sciences, Inc. entered into Third Note with the Investor valued at Principal amount $99,614.04, due April 6, 2027 (later extended) (effective 2026-04-06).
  evidence_excerpt: disclosed, on February 12, 2025, CV Sciences, Inc., a Delaware corporation (the “Company”) entered into a note purchase agreement (the “Original Purchase Agreement”) with an institutional investor (“Investor”), pursuant to which the Company issued and sold to the Investor a secured promissory note in the original principal amount of $1,600,000 (the “Original Note”).
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526151228/0001193125-26-151228-index.htm
- claim_id: c1384d69216ff974fed546a7588235c8f9b822a8
  claim: CV Sciences, Inc. amended April Amendment with the Investor valued at Third Note principal amount $99,614.04; conversion price changed to $0.03 per share; maturity date o (effective 2026-04-09).
  evidence_excerpt: On April 9, 2026, the Company and the Investor entered into an agreement (the "April Amendment") to amend the Notes to implement a new fixed conversion price equal to $0.03 per share.
  evidence_url: https://www.sec.gov/Archives/edgar/data/1510964/000119312526151228/0001193125-26-151228-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.